In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers.


Journal

Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203

Informations de publication

Date de publication:
Dec 2019
Historique:
entrez: 3 4 2019
pubmed: 3 4 2019
medline: 15 5 2019
Statut: ppublish

Résumé

A combination of biochemical, biophysical and biological techniques was used to study calf thymus DNA interaction with newly synthesized 7-MEOTA-tacrine thiourea 12-17 and urea heterodimers 18-22, and to measure interference with type I and II topoisomerases. Their biological profile was also inspected in vitro on the HL-60 cell line using different flow cytometric techniques (cell cycle distribution, detection of mitochondrial membrane potential dissipation, and analysis of metabolic activity/viability). The compounds exhibited a profound inhibitory effect on topoisomerase activity (e.g. compound 22 inhibited type I topoisomerase at 1 µM concentration). The treatment of HL-60 cells with the studied compounds showed inhibition of cell growth especially with hybrids containing thiourea (14-17) and urea moieties (21 and 22). Moreover, treatment of human dermal fibroblasts with the studied compounds did not indicate significant cytotoxicity. The observed results suggest beneficial selectivity of the heterodimers as potential drugs to target cancer cells.

Identifiants

pubmed: 30938202
doi: 10.1080/14756366.2019.1593159
pmc: PMC6450562
doi:

Substances chimiques

7-methoxy-1,2,3,4-tetrahydroacridin-9-amine 0
Acridines 0
Antineoplastic Agents 0
Tacrine 4VX7YNB537
Thiourea GYV9AM2QAG

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

877-897

Références

Clin Cancer Res. 1999 Dec;5(12):4295-300
pubmed: 10632373
J Med Chem. 2000 Apr 6;43(7):1350-8
pubmed: 10753472
J Pharmacol Exp Ther. 2000 Jul;294(1):160-7
pubmed: 10871308
J Pharm Pharmacol. 2001 Jan;53(1):83-8
pubmed: 11206196
Annu Rev Pharmacol Toxicol. 2001;41:53-77
pubmed: 11264450
J Clin Pharm Ther. 2001 Dec;26(6):405-16
pubmed: 11722677
Crit Rev Oncol Hematol. 2003 Jan;45(1):91-108
pubmed: 12482574
Drug Discov Today. 2003 Jan 15;8(2):67-77
pubmed: 12565009
Cell Death Differ. 2003 Jun;10(6):709-17
pubmed: 12761579
Pharmacol Ther. 2003 Aug;99(2):167-81
pubmed: 12888111
Hepatology. 2003 Sep;38(3):715-25
pubmed: 12939598
J Mol Biol. 1961 Feb;3:18-30
pubmed: 13761054
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Mar 5;801(2):229-35
pubmed: 14751791
Nature. 1952 Apr 26;169(4304):712-3
pubmed: 14956997
Expert Opin Emerg Drugs. 2004 May;9(1):105-33
pubmed: 15155139
CA Cancer J Clin. 2005 May-Jun;55(3):178-94
pubmed: 15890640
Pharm Res. 2005 Jul;22(7):1069-78
pubmed: 16028007
Apoptosis. 2005 Dec;10(6):1497-514
pubmed: 16215684
Toxicol In Vitro. 2006 Sep;20(6):824-31
pubmed: 16472967
Toxicol Sci. 2006 May;91(1):132-9
pubmed: 16510557
Bioorg Med Chem. 2006 Aug 15;14(16):5467-80
pubmed: 16713270
Biochem Pharmacol. 2007 Jun 15;73(12):1863-72
pubmed: 17391647
Chemistry. 2007;13(18):5075-81
pubmed: 17465426
Angew Chem Int Ed Engl. 2007;46(23):4374-8
pubmed: 17477461
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
Mutat Res. 2007 Oct 1;623(1-2):83-97
pubmed: 17681352
Spectrochim Acta A Mol Biomol Spectrosc. 2008 Jun;70(1):136-43
pubmed: 17825605
Bioorg Med Chem. 2008 Apr 1;16(7):3976-84
pubmed: 18258438
Expert Rev Anticancer Ther. 2008 May;8(5):819-31
pubmed: 18471053
Curr Drug Metab. 2008 May;9(4):332-5
pubmed: 18473751
Biochem Biophys Res Commun. 1991 Apr 30;176(2):690-7
pubmed: 1851000
Spectrochim Acta A Mol Biomol Spectrosc. 2008 Dec 15;71(4):1617-22
pubmed: 18701343
Nat Rev Cancer. 2009 May;9(5):338-50
pubmed: 19377506
Int J Biol Macromol. 2009 Aug 1;45(2):174-80
pubmed: 19414028
Chem Biol Drug Des. 2009 Aug;74(2):101-20
pubmed: 19566697
Biosci Rep. 2010 Apr 21;30(5):331-40
pubmed: 19691448
Curr Med Chem. 2010;17(17):1825-38
pubmed: 20345341
DNA Cell Biol. 2010 Oct;29(10):639-46
pubmed: 20590475
Toxicol In Vitro. 1999 Aug-Oct;13(4-5):683-8
pubmed: 20654534
Curr Med Chem. 2010;17(35):4270-90
pubmed: 20939813
J Phys Chem B. 2010 Nov 25;114(46):14842-53
pubmed: 21038894
Surg Today. 2011 Sep;41(9):1196-9
pubmed: 21874414
Nat Rev Mol Cell Biol. 2011 Nov 23;12(12):827-41
pubmed: 22108601
Eur J Med Chem. 2012 Sep;55:23-31
pubmed: 22818849
Eur J Med Chem. 2012 Nov;57:283-95
pubmed: 23072739
Molecules. 2013 Feb 20;18(2):2397-418
pubmed: 23429378
J Photochem Photobiol B. 2013 Nov 5;128:20-6
pubmed: 23994435
Curr Alzheimer Res. 2013 Oct;10(8):893-906
pubmed: 24093535
Int J Biol Macromol. 2014 Mar;64:53-62
pubmed: 24296409
N Engl J Med. 1986 Nov 13;315(20):1241-5
pubmed: 2430180
Expert Opin Ther Pat. 2014 Jun;24(6):647-64
pubmed: 24848259
Eur J Med Chem. 2014 Jul 23;82:426-38
pubmed: 24929293
J Med Chem. 2014 Oct 23;57(20):8576-89
pubmed: 25259726
J Med Chem. 2015 Jan 8;58(1):41-71
pubmed: 25387153
Int J Biol Macromol. 2015 Feb;73:9-16
pubmed: 25453293
Cancer Res. 1989 Sep 15;49(18):5077-82
pubmed: 2548710
Bioorg Chem. 2015 Apr;59:168-76
pubmed: 25827869
ACS Med Chem Lett. 2015 Feb 23;6(4):481-5
pubmed: 25941559
Arch Biochem Biophys. 2015 Jun 15;576:49-60
pubmed: 25951786
Eur J Pharm Sci. 2015 Aug 30;76:192-202
pubmed: 25960253
J Phys Chem B. 2015 Aug 27;119(34):11099-105
pubmed: 26061788
Int J Oncol. 2015 Oct;47(4):1572-84
pubmed: 26252082
J Med Chem. 2015 Nov 25;58(22):8985-9003
pubmed: 26503905
Toxicol Lett. 2016 Jan 22;243:56-66
pubmed: 26721606
Anticancer Drug Des. 1989 Dec;4(4):241-63
pubmed: 2695099
Eur J Med Chem. 2016 Jun 10;115:179-90
pubmed: 27017547
Biochim Biophys Acta. 2016 Jul;1860(7):1519-27
pubmed: 27095671
Br J Cancer. 2016 Jun 28;115(1):5-11
pubmed: 27140313
Mol Biosyst. 2016 Aug 16;12(9):2910-20
pubmed: 27412811
Curr Top Med Chem. 2017;17(9):1006-1026
pubmed: 27697055
Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):607-619
pubmed: 27865910
Spectrochim Acta A Mol Biomol Spectrosc. 2017 Mar 15;175:155-163
pubmed: 28033562
Br J Pharmacol. 1989 Sep;98(1):79-86
pubmed: 2804555
Molecules. 2017 Jul 28;22(8):null
pubmed: 28788095
J Mol Biol. 1974 Jun 25;86(2):469-89
pubmed: 4416620
Proc Natl Acad Sci U S A. 1984 Mar;81(5):1361-5
pubmed: 6324188
Arch Toxicol. 1983 Oct;54(2):163-6
pubmed: 6651529
J Med Chem. 1978 Sep;21(9):868-74
pubmed: 722754
Act Nerv Super (Praha). 1981 Dec;23(4):292-3
pubmed: 7336867
Biochemistry. 1995 Oct 17;34(41):13682-7
pubmed: 7577959
J Mol Recognit. 1994 Jun;7(2):141-55
pubmed: 7826674
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11007-11
pubmed: 7971998
JAMA. 1994 Apr 6;271(13):992-8
pubmed: 8139084
Biochim Biophys Acta. 1977 May 17;476(2):122-30
pubmed: 861227
Mol Pharmacol. 1996 May;49(5):772-80
pubmed: 8622625
J Med Chem. 1997 Feb 14;40(4):449-54
pubmed: 9046334
Biochem Pharmacol. 1997 Oct 1;54(7):755-9
pubmed: 9353129
Methods Mol Biol. 1997;90:195-218
pubmed: 9407537
Arch Toxicol. 1998 May;72(6):362-71
pubmed: 9657284
Neurochem Int. 1998 May-Jun;32(5-6):413-9
pubmed: 9676739

Auteurs

Jana Janockova (J)

a Department of Biochemistry, Institute of Chemistry, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.
b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.

Jan Korabecny (J)

b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.
c Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Hradec Kralove , Czech Republic.

Jana Plsikova (J)

a Department of Biochemistry, Institute of Chemistry, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.
d Associated Tissue Bank, Faculty of Medicine , P.J. Šafárik University , Kosice , Slovak Republic.

Katerina Babkova (K)

b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.
c Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Hradec Kralove , Czech Republic.

Eva Konkolova (E)

a Department of Biochemistry, Institute of Chemistry, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.

Dana Kucerova (D)

e Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.

Jana Vargova (J)

e Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.

Jan Koval (J)

e Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.

Rastislav Jendzelovsky (R)

e Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.

Peter Fedorocko (P)

e Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.

Jana Kasparkova (J)

f Department of Biophysics, Faculty of Science , Palacke University , Olomouc , Czech Republic.

Viktor Brabec (V)

f Department of Biophysics, Faculty of Science , Palacke University , Olomouc , Czech Republic.

Jan Rosocha (J)

d Associated Tissue Bank, Faculty of Medicine , P.J. Šafárik University , Kosice , Slovak Republic.

Ondrej Soukup (O)

b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.
c Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Hradec Kralove , Czech Republic.

Slavka Hamulakova (S)

g Department of Organic Chemistry, Institute of Chemistry, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.

Kamil Kuca (K)

b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.

Maria Kozurkova (M)

a Department of Biochemistry, Institute of Chemistry, Faculty of Science , P. J. Šafárik University , Kosice , Slovak Republic.
b Biomedical Research Center , University Hospital Hradec Kralove , Hradec Kralove , Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH